Antibodies

View as table Download

Carrier-free (BSA/glycerol-free) EIF2AK2 mouse monoclonal antibody,clone OTI3F5

Applications IHC, WB
Reactivities Human
Conjugation Unconjugated

EIF2AK2 mouse monoclonal antibody,clone OTI3F5

Applications IHC, WB
Reactivities Human
Conjugation Unconjugated

EIF2AK2 mouse monoclonal antibody,clone OTI3F5

Applications IHC, WB
Reactivities Human
Conjugation Unconjugated

PKR (EIF2AK2) pThr451 rabbit polyclonal antibody, Aff - Purified

Applications IHC, WB
Reactivities Human
Conjugation Unconjugated

PKR (EIF2AK2) pThr446 rabbit polyclonal antibody, Aff - Purified

Applications WB
Reactivities Human
Conjugation Unconjugated

Anti-EIF2AK2 Rabbit Polyclonal Antibody

Applications IHC
Reactivities Human
Conjugation Unconjugated
Immunogen Synthetic peptide corresponding to a region derived from 438-451 amino acids of Human eukaryotic translation initiation factor 2-alpha kinase 2

PKR (EIF2AK2) rabbit polyclonal antibody, Aff - Purified

Applications IHC, WB
Reactivities Human
Conjugation Unconjugated

Rabbit Polyclonal PKR (Thr446) Antibody (Phospho-specific)

Applications WB
Reactivities Human
Conjugation Unconjugated
Immunogen The antiserum was produced against A synthesized peptide derived from human PKR around the phosphorylation site of Threonine 446
Modifications Phospho-specific

Rabbit polyclonal PKR (Ab-451) antibody

Applications IHC
Reactivities Human, Mouse
Conjugation Unconjugated
Immunogen The antiserum was produced against synthesized non-phosphopeptide derived from human PKR around the phosphorylation site of threonine 451(K-G-TP-L-R).

Rabbit Polyclonal PKR Antibody

Applications WB
Reactivities Human
Conjugation Unconjugated
Immunogen The antiserum was produced against A synthesized peptide derived from human PKR

PKR (EIF2AK2) rabbit polyclonal antibody, Aff - Purified

Applications IHC
Reactivities Human
Conjugation Unconjugated

Rabbit polyclonal PKR (Thr451) antibody(Phospho-specific)

Applications IHC
Reactivities Human, Mouse
Conjugation Unconjugated
Immunogen The antiserum was produced against synthesized phosphopeptide derived from human PKR around the phosphorylation site of threonine 451(K-G-TP-L-R).
Modifications Phospho-specific